Vaccines Market by Type and Geography - Forecast and Analysis 2020-2024

Vaccines Market by Type and Geography - Forecast and Analysis 2020-2024

Global Vaccines Market: About this market

Technavio’s vaccines market analysis considers sales from both prophylactic vaccines and therapeutic vaccine types. Our analysis also considers the sales of vaccines in Asia, Europe, North America, and ROW. In 2019, the prophylactic vaccines segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as high safety and efficacy will play a significant role in the prophylactic vaccines segment to maintain its market position. Also, our global vaccines market report looks at factors such as increased funding for vaccine development and new vaccine launches, approval of vaccines and strong pipeline, and increasing use of adjuvants in vaccines. However, high costs of vaccine research, development, and manufacturing, product recalls, and safety concerns may hamper the growth of the vaccines industry over the forecast period.

Global Vaccines Market: Overview

Increasing the use of adjuvants in vaccines

With the increasing use of vaccines to treat and prevent life-threatening diseases, vendors are focusing on strategies for the development of effective new vaccines and usage of suitable adjuvants. They work by improving the humoral and cell-mediated immune response to vaccine antigens. The rise of the use of adjuvants, such as immunologic adjuvants, in new vaccines has increased to combat emerging new pathogens and re-emerging old pathogens. The demand for such vaccines is also high because of their long-lasting protective immune response. This will lead to the expansion of the global vaccines market at a CAGR of almost 7% during the forecast period.

Development of nanoparticle vaccines

The nanoparticle-based vaccines have higher immunization and targeted delivery attributes. This has led the vendors to invest in R&D of nanoparticle vaccines due to the ongoing research to develop vaccines against specific diseases. For instance, prophylactic vaccines are associated with the risk of regaining their pathogenicity under certain immunocompromised conditions. This limitation can be overcome by using nanoparticle vaccines. Such development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global vaccines market during the forecast period 2020-2024, click here.

Competitive Landscape

With the presence of a few major players, the global vaccines market is concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading vaccines manufacturers, that include Bavarian Nordic AS, CSL Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Novavax Inc., Pfizer Inc., and Sanofi

Also, the vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
      • Table Product overview
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
    • Parent market
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2019
      • Table Market size 2019
    • Market size and forecast 2019-2024
      • Table Global market: Size and forecast 2019-2024 ($ millions)
      • Table Global market: Year-over-year growth 2020-2024 (%)
  • Five forces analysis
    • Table Five forces analysis 2019
    • Table Five forces analysis 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market segmentation by type
    • Table Type - Market share 2019-2024 (%)
    • Comparison by type
      • Table Comparison by type
    • Prophylactic vaccines - Market size and forecast 2019-2024
      • Table Prophylactic vaccines - Market size and forecast 2019-2024 ($ millions)
      • Table Prophylactic vaccines - Year-over-year growth 2020-2024 (%)
    • Therapeutic vaccines - Market size and forecast 2019-2024
      • Table Therapeutic vaccines - Market size and forecast 2019-2024 ($ millions)
      • Table Therapeutic vaccines - Year-over-year growth 2020-2024 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2019-2024
      • Table North America - Market size and forecast 2019-2024 ($ millions)
      • Table North America - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ millions)
      • Table Europe - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2019-2024
      • Table Asia - Market size and forecast 2019-2024 ($ millions)
      • Table Asia - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ millions)
      • Table ROW - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision Framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • R&D of novel vaccines
    • Development of nanoparticle vaccines
    • Advancement in vaccine delivery system
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bavarian Nordic AS
      • Table Bavarian Nordic AS - Vendor overview
      • Table Bavarian Nordic AS - Business segments
      • Table Bavarian Nordic AS - Organizational developments
      • Table Bavarian Nordic AS - Geographic focus
      • Table Bavarian Nordic AS - Key offerings
      • Table Bavarian Nordic AS - Key customers
    • CSL Ltd.
      • Table CSL Ltd. - Vendor overview
      • Table CSL Ltd. - Business segments
      • Table CSL Ltd. - Organizational developments
      • Table CSL Ltd. - Geographic focus
      • Table CSL Ltd. - Segment focus
      • Table CSL Ltd. - Key offerings
      • Table CSL Ltd. - Key customers
    • Emergent BioSolutions Inc.
      • Table Emergent BioSolutions Inc. - Vendor overview
      • Table Emergent BioSolutions Inc. - Business segments
      • Table Emergent BioSolutions Inc. - Organizational developments
      • Table Emergent BioSolutions Inc. - Key offerings
      • Table Emergent BioSolutions Inc. - Key customers
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Vendor overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Organizational developments
      • Table GlaxoSmithKline Plc - Geographic focus
      • Table GlaxoSmithKline Plc - Segment focus
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Key customers
    • Inovio Pharmaceuticals Inc.
      • Table Inovio Pharmaceuticals Inc. - Vendor overview
      • Table Inovio Pharmaceuticals Inc. - Business segments
      • Table Inovio Pharmaceuticals Inc. - Organizational developments
      • Table Inovio Pharmaceuticals Inc. - Key offerings
      • Table Inovio Pharmaceuticals Inc. - Key customers
    • Merck & Co. Inc.
      • Table Merck & Co. Inc. - Vendor overview
      • Table Merck & Co. Inc. - Business segments
      • Table Merck & Co. Inc. - Organizational developments
      • Table Merck & Co. Inc. - Geographic focus
      • Table Merck & Co. Inc. - Segment focus
      • Table Merck & Co. Inc. - Key offerings
      • Table Merck & Co. Inc. - Key customers
    • Mitsubishi Tanabe Pharma Corp.
      • Table Mitsubishi Tanabe Pharma Corp. - Vendor overview
      • Table Mitsubishi Tanabe Pharma Corp. - Business segments
      • Table Mitsubishi Tanabe Pharma Corp. - Organizational developments
      • Table Mitsubishi Tanabe Pharma Corp. - Geographic focus
      • Table Mitsubishi Tanabe Pharma Corp. - Key offerings
      • Table Mitsubishi Tanabe Pharma Corp. - Key customers
    • Novavax Inc.
      • Table Novavax Inc. - Vendor overview
      • Table Novavax Inc. - Business segments
      • Table Novavax Inc. - Organizational developments
      • Table Novavax Inc. - Key offerings
      • Table Novavax Inc. - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
    • Sanofi
      • Table Sanofi - Vendor overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
      • Table Sanofi - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook